BioSpace News Archive

Business

Current Biologics names chief executive

The board of Current Biologics has selected Tom Hochuli as chief executive officer of the startup company, which is focused on providing cell and gene therapy manufacturing and development services to the biotechnology and pharmaceutical industries.

September 20, 2022
·
3 min read
FDA

Zimmer Biomet Receives FDA Clearance for Identity™ Shoulder System for Shoulder Replacement

Zimmer Biomet Holdings, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Identity™ Shoulder System for anatomic, reverse and revision shoulder replacement.

September 20, 2022
·
5 min read
Biotech Beach

PreludeDx™ Announces Publication of Residual Risk after Radiation Therapy Data in the International Journal of Radiation Oncology•Biology•Physics

Prelude Corporation today announced the publication of clinical study data in the International Journal of Radiation Oncology· Biology· Physics (“Red Journal”).

September 20, 2022
·
4 min read
Business

Octagon Therapeutics Enters Inflammation-Focused Research Alliance with Novo Nordisk

Octagon Therapeutics today announced the initiation of a research collaboration with Novo Nordisk focused on inflammatory disease.

September 20, 2022
·
1 min read
Policy

See a more complete picture of your health with Index BPM, an FDA-cleared smart blood pressure monitor from Garmin

Garmin International, Inc., a unit of Garmin Ltd., announced the Index™ BPM, its first smart blood pressure monitor that lets users measure and track systolic and diastolic blood pressure at home or on the go.

September 20, 2022
·
4 min read
Genetown

Vizgen Unveils MERSCOPE™ Protein Co-detection Kit Enabling Simultaneous Imaging of Transcripts and Proteins in a Single Experiment

Vizgen Unveils MERSCOPE™ Protein Co-detection Kit Enabling Simultaneous Imaging of Transcripts and Proteins in a Single Experiment.

September 20, 2022
·
2 min read
Genetown

Alnylam Receives Approval in Europe for AMVUTTRA® (vutrisiran) for the Treatment of Hereditary Transthyretin-mediated (hATTR) Amyloidosis in Adult Patients with Stage 1 or Stage 2 Polyneuropathy

Alnylam Receives Approval in Europe for AMVUTTRA ® (vutrisiran) for the Treatment of Hereditary Transthyretin-mediated (hATTR) Amyloidosis in Adult Patients with Stage 1 or Stage 2 Polyneuropathy.

September 20, 2022
·
10 min read
FDA

AVROBIO Receives Rare Pediatric Disease Designation from U.S. Food and Drug Administration (FDA) for First Gene Therapy in Development for Cystinosis

AVROBIO, Inc today announced that the U.S. Food and Drug Administration (FDA) has granted rare pediatric disease designation to AVR-RD-04.

September 20, 2022
·
7 min read
Business

OpGen Subsidiary Curetis and FIND Sign R&D Collaboration Agreement for Unyvero A30 RQ Platform

OpGen, Inc. announced the signing of an R&D collaboration agreement with FIND, the global alliance for diagnostics, for the Unyvero A30 RQ platform for use in rapid pathogen ID and AMR testing from blood culture samples in low and middle income countries.

September 20, 2022
·
5 min read
Business

Gain Therapeutics Announces Promotion of Matthias Alder to Chief Executive Officer

Gain Therapeutics, Inc. today announced that Matthias Alder, the Company’s current Chief Operating Officer, has been appointed as the Company’s Chief Executive Officer, effective immediately.

September 20, 2022
·
5 min read